SERS for Point-of-care and Clinical Applications
SERS-based molecular sentinel nanoprobes for nucleic acid biomarker detection
Publication
, Chapter
Crawford, B; Wang, HN; Vo-Dinh, T
January 1, 2022
This chapter presents an overview of SERS molecular sentinels for cancer detection.
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Crawford, B., Wang, H. N., & Vo-Dinh, T. (2022). SERS-based molecular sentinel nanoprobes for nucleic acid biomarker detection. In SERS for Point-of-care and Clinical Applications (pp. 135–167). https://doi.org/10.1016/B978-0-12-820548-8.00005-9
Crawford, B., H. N. Wang, and T. Vo-Dinh. “SERS-based molecular sentinel nanoprobes for nucleic acid biomarker detection.” In SERS for Point-of-Care and Clinical Applications, 135–67, 2022. https://doi.org/10.1016/B978-0-12-820548-8.00005-9.
Crawford B, Wang HN, Vo-Dinh T. SERS-based molecular sentinel nanoprobes for nucleic acid biomarker detection. In: SERS for Point-of-care and Clinical Applications. 2022. p. 135–67.
Crawford, B., et al. “SERS-based molecular sentinel nanoprobes for nucleic acid biomarker detection.” SERS for Point-of-Care and Clinical Applications, 2022, pp. 135–67. Scopus, doi:10.1016/B978-0-12-820548-8.00005-9.
Crawford B, Wang HN, Vo-Dinh T. SERS-based molecular sentinel nanoprobes for nucleic acid biomarker detection. SERS for Point-of-care and Clinical Applications. 2022. p. 135–167.